BudgetState Hospitals / Treatments / Internal medicine
Internal medicine
Melanoma
For this treatment hospitals report no wait time.
Quality figures for report year 2025: 3 indicators, as the hospitals reported them.
Sorts by distance; your choice stays in your browser.
within the Treeknormover it, up to one and a half timesmore than one and a half timesnot reported
| Hospital | Distance | New patients with inoperable melanoma (stage III/IV)number per year | Alive 1 year after diagnosis (stage III/IV)higher is better | Alive 2 years after diagnosis (stage III/IV)higher is better |
|---|---|---|---|---|
| The Netherlandsmedian of 0 hospitals | 67 | 62.3% | 48.2% | |
| AmphiaBreda | 69 | 55.5% | 47.3% | |
| Amsterdam UMCAmsterdam | 65 | 66.8% | 59.1% | |
| Antoni van LeeuwenhoekAmsterdam | 99 | 61.0% | 48.7% | |
| Erasmus MCRotterdam | 124 | 63.0% | 49.1% | |
| Frisius MCLeeuwarden | 44 | 62.3% | 49.4% | |
| IsalaZwolle | 70 | 64.5% | 46.8% | |
| LUMCLeiden | 109 | 60.2% | 37.9% | |
| Maastricht UMC+Maastricht | 51 | 67.2% | 41.9% | |
| Medisch Spectrum TwenteEnschede | 36 | 58.7% | 58.9% | |
| Máxima MCVeldhoven | 36 | 48.0% | 44.0% | |
| RadboudumcNijmegen | 71 | 67.4% | 47.7% | |
| UMC UtrechtUtrecht | 84 | 69.8% | 60.3% | |
| UMCGGroningen | 62 | 58.9% | 48.8% | |
| ZuyderlandHeerlen | 24 | 62.4% | 45.4% |
Wait: the shortest across the hospital's locations, latest report up to 27 October 2026. The colour measures a wait against the Treeknorm, the position against the other hospitals: position 1 is the shortest, equal waits share a position. Quality: report year 2025. Click a column heading to sort.